Summary

Errata: Detection of Exosomal Biomarker by Electric Field-induced Release and Measurement (EFIRM)

Published: January 10, 2023
doi:

Abstract

Protocol

An erratum was issued for Detection of Exosomal Biomarker by Electric Field-induced Release and Measurement (EFIRM). The disclosures were updated from:

David Wong is co-founder of RNAmeTRIX Inc., a molecular diagnostic company. PeriRx LLC sublicensed intellectual properties pertaining to molecular diagnostics from RNAmeTRIX. David Wong is a consultant to PeriRx.

para

David T. Wong is co-founder of RNAmeTRIX Inc., a molecular diagnostic company. He holds equity in RNAmeTRIX, and serves as a company director and scientific advisor. The University of California also holds equity in RNAmeTRIX. Intellectual property that David T. Wong invented and which was patented by the University of California has been licensed to RNAmeTRIX. Additionally, he is a paid consultant to PeriRx.

Declarações

The authors have nothing to disclose.

Citar este artigo
Errata: Detection of Exosomal Biomarker by Electric Field-induced Release and Measurement (EFIRM). J. Vis. Exp. (Pending Publication), e5755, doi:10.3791/5755 (2023).

View Video